|
US2020330429A1
|
|
Method of treating truncal acne with trifarotene
|
|
EP3730938A1
|
|
New method to visualize distribution profile of penetration of compound(s) through the nail
|
|
WO2019121694A1
|
|
Injectable compositions of cross-linked hyaluronic acid and bupivacaine, and uses thereof
|
|
CN112041378A
|
|
Injectable gel products
|
|
EP3659632A1
|
|
Post-crosslinking partial degradation of amide crosslinked hydrogels
|
|
WO2019002370A1
|
|
Crosslinked and functionalized glycosaminoglycans
|
|
WO2019002369A1
|
|
Glycosaminoglycan hydrogel with grafted dextran or cyclodextrin
|
|
WO2019002368A1
|
|
Crosslinked and functionalized glycosaminoglycans
|
|
WO2019002372A1
|
|
Method of preparing a hydrogel product
|
|
WO2019002371A1
|
|
Glycosaminoglycan gel with bis-tris buffer
|
|
WO2018207119A1
|
|
Conical needle and methods of use and manufacturing
|
|
WO2019001784A1
|
|
Hyaluronic acid gel with a divalent cation
|
|
US2018228427A1
|
|
Systems and methods for itch monitoring and measurement
|
|
EP3562468A1
|
|
Micro- or nanoparticular multilamellar vesicles, compositions comprising the same and method for their use in skin care
|
|
EP3562470A1
|
|
Composition comprising a crosslinked hyaluronic acid (ha) in combination with a low-molecular ha and/or an agent stimulating endogenous ha synthesis
|
|
WO2018122343A1
|
|
Micro- or nanoparticular vesicles comprising crosslinked hyaluronic acid, compositions comprising the same and method for their use in skin care
|
|
WO2018122256A1
|
|
Biointegration of dermal fillers
|
|
NL2020080B1
|
|
Capsule comprising a probiotic microorganism for use in a composition production and distribution device
|
|
CN110546479A
|
|
Measurement of flexibility of injectable gels
|
|
WO2018083196A1
|
|
Compositions comprising a compound of the avermectin family for the treatment and/or prevention of hand eczema
|
